… Acquired hemophilia is a serious coagulopathy usually affecting the elderly, persons with
autoimmune … Acquired hemophilia is an autoimmune disease resulting from the presence of …

… Acquired hemophilia A is a rare but severe autoimmune … state of knowledge regarding
acquired hemophilia A, analyzing its … state of knowledge in acquired hemophilia A, with particular …

Acquired hemophilia A is a rare, autoimmune disorder that is caused by autoantibodies that
act as inhibitors to factor VIII. It is characterized by severe, unexpected bleeding that may be …

Acquired hemophilia A (AHA) is a rare disease resulting from autoantibodies (inhibitors)
against endogenous factor VIII (FVIII) that leads to bleeding, which is often spontaneous and …

… Diagnostic pathway for acquired hemophilia A. The activated … anticoagulant does not
exclude acquired hemophilia A. See … of hemostatic therapy in acquired hemophilia A. rFVIIa, …

… interest and expertise in the management of acquired hemophilia. The need for increased
… of acquired hemophilia among health care professionals to whom acquired hemophilia …

Objectives: Acquired hemophilia A (AHA) is a rare, but potentially life-threatening, bleeding
disorder caused by an autoantibody against factor VIII that interferes with its coagulant …

… Acquired hemophilia A (AHA) is a rare acquired bleeding disorder caused by autoantibodies
against autologous factor VIII (FVIII). It is a disease that most commonly affects the elderly, …

… It is still not clear why the bleeding manifestation in congenital hemophilia A … hemophiliacs
who develop inhibitors; this is likely due to a delay in the diagnosis of acquired hemophilia. As …

… The reaction kinetic of the interaction between factor VIII and the inactivating antibody in
acquired hemophilia (autoantibodies) differs from the pattern seen in congenital hemophilia …